Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (17409)	3/13/1998 3:59:00 PM
From: lrb	Read Replies (1) \| Respond to of 32384

[off topic; correction] > Then there is MGI-114 (on the MGI thread, it has been likened to > a "lottery ticket.") This is a highly promising cancer drug, > currently completing Phase II. Actually, MGI-114 is currently completing Phase I, and the company is still evaluating which types of tumors to target for Phase II. See Message 3603477 et al.

To: Russian Bear who wrote (17409)	3/13/1998 5:17:00 PM
From: WTDEC	Respond to of 32384

RB, excellent analysis. I bought some MOGN back in early January based on skimpy analysis, which I rarely do, but I have lurked on the MOGN thread since. Your summary says it all. Best of luck. Walter